반응식
Cl.[NH:2]1[CH2:5][CH2:4][CH2:3]1.[CH:6]([C:8]1[CH:9]=[C:10]([CH2:14][C:15]([NH:17][C:18]2[CH:19]=[N:20][CH:21]=[C:22]([C:24]([C:26]3[C:34]4[CH:33]=[N:32][CH:31]=[N:30][C:29]=4[N:28]([CH:35]([CH3:37])[CH3:36])[CH:27]=3)=[O:25])[CH:23]=2)=[O:16])[CH:11]=[CH:12][CH:13]=1)=O.[C:38]([OH:41])(=[O:40])C.[C:42]([O:45][BH-](OC(=O)C)OC(=O)C)(=[O:44])C.[Na+]>C(Cl)Cl.O>[CH:38]([OH:41])=[O:40].[N:2]1([CH2:6][C:8]2[CH:9]=[C:10]([CH2:14][C:15]([NH:17][C:18]3[CH:19]=[N:20][CH:21]=[C:22]([C:24]([C:26]4[C:34]5[CH:33]=[N:32][CH:31]=[N:30][C:29]=5[N:28]([CH:35]([CH3:37])[CH3:36])[CH:27]=4)=[O:25])[CH:23]=3)=[O:16])[CH:11]=[CH:12][CH:13]=2)[CH2:5][CH2:4][CH2:3]1.[CH:42]([O-:45])=[O:44]참가 물질
8
반응물 4
생성물 2
시약·촉매·용매 2
실험 절차
Azetidine hydrochloride (10 mg, 0.11 mmol) was added to a stirred solution of 2-(3-formylphenyl)-N-{5-[(7-isopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)carbonyl]pyridin-3-yl}acetamide (Preparation 192, 23 mg, 0.05 mmol) in DCM (1 mL) and acetic acid (0.04 mL, 0.60 mmol). The reaction mixture was stirred for 30 min at room temperature before addition of sodium triacetoxyborohydride (29 mg, 0.14 mmol) and stirring continued for 3 hours. Water (1 mL) was added and the mixture concentrated in vacuo (with toluene azeotroping). The residue was purified by preparative HPLC to afford the title compound as a formate salt in 12% yield, 3.4 mg.
후처리
- concentrationthe mixture concentrated in vacuo (with toluene azeotroping)
- customThe residue was purified by preparative HPLC
출처 및 근거
- ORD 기록
- ord-d2d80c6da06f4393a1275495ee8ff960
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08846698B2
연결된 노트
불러오는 중…